🇯🇵 日本語 🇺🇸 English
3,810 companies 9,274 AI summaries 7,081 risk analyses 3,506 growth scores Register free — watchlist & alerts →
EDINET 4043 Positive Risk Analyzed 📈 Growth 6/10

Tokuyama Corporation

Annual Securities Report - 162nd Term(2025/04/01 - 2026/03/31) ／ 2026-06-19 13:50

Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).

EarningsRestructuringImpairmentDemandNew MarketCapacityM&A/Alliance
AI Summary 2026-06-19 18:57

Tokuyama posted revenue of ¥349.5B (+1.9% YoY) and operating profit of ¥37.0B (+23.5% YoY) for FY3/2026, driven by robust semiconductor-related product sales and improved manufacturing costs. Net profit attributable to shareholders declined 5.1% due to a provision for a long-term power purchase contract and deferred tax adjustments.

KEY POINTS
  • Operating profit surged +23.5% (¥29,968M → ¥37,017M), driven by firm semiconductor material sales and a 4.4% reduction in cost of sales
  • Net profit attributable to shareholders fell -5.1% (¥23,388M → ¥22,205M) due to special losses from a power contract provision and a ¥8,355M deferred tax adjustment
  • Major restructuring underway: cement business to be transferred to Taiheiyo Cement in Oct 2026, manufacturing halt planned by FY2028; new JV for semiconductor-grade polysilicon established in Malaysia
📊 Revenue
Revenue +1.9% (¥343,073M → ¥349,476M)
💰 Operating profit
OP +23.5% (¥29,968M → ¥37,017M)
🔮 Outlook
New mid-term plan (2030) unveiled, focusing on Electronics, Health & Life Sciences, and Environment. Specific numerical guidance for next fiscal year not disclosed in this filing.
📈 Growth outlook 📈 Growth 6/10
Growth driven by semiconductor material demand (polysilicon, high-purity chemicals) and the newly consolidated life-science business. Portfolio shift away from cement toward high-margin electronics and health segments is expected to improve earnings quality.
Growth drivers
  • Semiconductor polysilicon capacity expansion via new Vietnam plant and Malaysia JV with OCI Group
  • Life Sciences segment revenue +17.7% YoY from newly consolidated in-vitro diagnostics and dental materials businesses
  • Reallocation of management resources to Electronics/Health/Environment growth segments following cement business divestiture
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
⚠️ Extracted Risk Factors
CategoryDescriptionScoreNew
Business Performance Risk Delays in ramping up polysilicon production facilities in Vietnam and Malaysia, combined with semiconductor demand volatility, could materially miss revenue targets for the Electronic Advanced Materials segment. 8/10
Climate Change Risk Tightening carbon pricing and GHG regulations may significantly raise operating costs. Failure to decarbonize fast enough risks product exclusion from green supply chains, while the planned cement business exit entails large transition costs. 7/10
Market Risk Continuing decline in domestic cement and commodity chemicals demand depresses earnings until the planned divestiture to Taiheiyo Cement is completed, while the growth business pivot may not proceed as scheduled. 7/10
Geopolitical / Supply Chain Risk Concentration of electronic materials production and sales in Taiwan, South Korea, and China exposes the company to geopolitical tensions, trade restrictions, or regulatory changes that could disrupt operations. 7/10
Foreign Exchange Risk Broad multi-currency exposure across Vietnam, Taiwan, South Korea, Malaysia and others means yen appreciation could materially reduce the yen-equivalent value of overseas revenues and net assets. 6/10
Regulatory Risk Increasingly frequent amendments to chemical regulations (REACH and equivalents) across multiple jurisdictions could lead to sales suspensions or penalties if compliance lags, despite zero-violation targets. 6/10
Disaster Risk A major earthquake or extreme weather event at the Tokuyama Works, where core production is concentrated, could cause prolonged multi-segment production shutdowns with significant financial impact. 6/10
Human Capital Risk Headcount fulfillment rate of 80% vs. the 100% target signals difficulty securing talent for the electronics and life science growth pivot, which could slow the planned business portfolio transformation. 5/10
8/10 Business Performance Risk
Delays in ramping up polysilicon production facilities in Vietnam and Malaysia, combined with semiconductor demand volatility, could materially miss revenue targets for the Electronic Advanced Materials segment.
7/10 Climate Change Risk
Tightening carbon pricing and GHG regulations may significantly raise operating costs. Failure to decarbonize fast enough risks product exclusion from green supply chains, while the planned cement business exit entails large transition costs.
7/10 Market Risk
Continuing decline in domestic cement and commodity chemicals demand depresses earnings until the planned divestiture to Taiheiyo Cement is completed, while the growth business pivot may not proceed as scheduled.
7/10 Geopolitical / Supply Chain Risk
Concentration of electronic materials production and sales in Taiwan, South Korea, and China exposes the company to geopolitical tensions, trade restrictions, or regulatory changes that could disrupt operations.
6/10 Foreign Exchange Risk
Broad multi-currency exposure across Vietnam, Taiwan, South Korea, Malaysia and others means yen appreciation could materially reduce the yen-equivalent value of overseas revenues and net assets.
6/10 Regulatory Risk
Increasingly frequent amendments to chemical regulations (REACH and equivalents) across multiple jurisdictions could lead to sales suspensions or penalties if compliance lags, despite zero-violation targets.
6/10 Disaster Risk
A major earthquake or extreme weather event at the Tokuyama Works, where core production is concentrated, could cause prolonged multi-segment production shutdowns with significant financial impact.
5/10 Human Capital Risk
Headcount fulfillment rate of 80% vs. the 100% target signals difficulty securing talent for the electronics and life science growth pivot, which could slow the planned business portfolio transformation.
X LinkedIn Threads Bluesky Facebook
Track Japanese disclosures with JSIGNAL

AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.

Start free — 30-day trial Login